Direct-to-consumer drug programs: What producers should know
Direct-to-consumer (DTC) prescription drug purchase programs are gaining attention as drug manufacturers, government platforms, and third-party vendors expand cash-pay pathways for select medications. These programs may be helpful for some people, especially those who are uninsured, paying cash, or using medications not covered by their benefit. However, they may also create confusion for members and employers because many of these purchases happen outside the pharmacy benefit.
What are DTC drug purchase programs?
DTC programs allow members to access select prescription drugs on a self-pay or cash-pay basis. These programs are often manufacturer-driven and may use third-party vendors, telehealth partners, retail pharmacies, or mail-order pharmacies.
Depending on the program, members may be able to:
- Search for a cash price
- Use a manufacturer-sponsored coupon
- Fill a prescription through a participating retail pharmacy
- Receive a medication through a mail-order pharmacy
- Connect with a telehealth provider, if a prescription is needed
These programs are not new, but they are becoming more visible as drug manufacturers expand cash-pay options and as federal efforts, such as TrumpRx, bring more attention to direct drug purchasing.
What is TrumpRx?
TrumpRx.gov launched in February 2026 as an online platform intended to help cash-paying members find discounted prices on select prescription drugs. TrumpRx does not sell or dispense medications directly. Instead, it refers members to manufacturer-sponsored websites or participating pharmacies where drugs may be purchased at a discounted cash price. For some drugs, the site provides printable or digital coupons that can be used at participating pharmacies. For other drugs, members may be directed to a manufacturer’s DTC program or mail-order option.
Why this matters now
The growth of GLP-1 weight loss medication use has made DTC drug access a mainstream topic. These medications have high demand, high list prices, and significant budget impact for employer-sponsored health plans. DTC programs usually are an open-access pathway that does not require that a member meets the plan’s medical necessity criteria. When a plan does not cover a medication or when a member does not meet the plan’s clinical criteria, members may seek access through DTC programs, telehealth platforms, or other pharmacy channels.
Potential advantages
DTC programs may offer some benefits for members and employers.
They may:
- Provide lower cash prices compared with a drug’s list price
- Help members access medications not covered by their plan
- Create more price transparency
- Increase competitive pressure in the prescription drug market
For certain drugs, especially those often paid for out-of-pocket, DTC programs may provide a more affordable option.
Potential concerns
While DTC programs may improve access for some members, they can also create new challenges. Drugs purchased outside the pharmacy benefit may not count toward a member’s deductible or out-of-pocket maximum. Members may also pay less through their insurance benefit than through a cash-pay program, depending on their plan design. DTC purchases may also limit visibility for the employer. When prescriptions are filled outside the pharmacy benefit, it may be harder to monitor adherence, duplicate therapy, drug interactions, safety concerns, and overall medication use. These programs may also add complexity for members who are already navigating a complex healthcare system.
Key takeaways
DTC programs are not a replacement for a pharmacy benefit, but another access pathway that may influence how members seek care and how employers think about affordability. DTC drug programs may offer lower cash prices for select medications, but they can also create confusion and reduce medication use visibility. DTC programs may help some members access lower cash prices, but they are not always the lowest cost or best clinical option for the member.
Read the full formulary update.